#OPERATION WARP SPEED VACCINES TRIAL#
#OPERATION WARP SPEED VACCINES LICENSE#

OWS’s role is to enable, accelerate, harmonize, and advise the companies developing the selected vaccines. Our objectives are based on advances in vaccine platform technology, improved understanding of safe and efficacious vaccine design, and similarities between the SARS-CoV-1 and SARS-CoV-2 disease mechanisms. SARS-CoV-2 vaccine development began in January, phase 1 clinical studies in March, and the first phase 3 trials in July. OWS aims to compress this time frame even further. The 2014 West African Ebola virus epidemic spurred rapid vaccine development, but though preclinical data existed before the outbreak, a period of 12 months was required to progress from phase 1 first-in-human trials to phase 3 efficacy trials. The pace and scope of such a vaccine effort are unprecedented. population - beginning at the end of 2020 and to have as many as 300 million doses of such vaccines available and deployed by mid-2021. The initiative set ambitious objectives: to deliver tens of millions of doses of a SARS-CoV-2 vaccine - with demonstrated safety and efficacy, and approved or authorized by the FDA for use in the U.S. OWS has engaged experts in all critical aspects of medical countermeasure research, development, manufacturing, and distribution to work in close coordination. We are drawing on expertise from the NIH, ASPR, the Centers for Disease Control and Prevention (CDC), the Biomedical Advanced Research and Development Authority (BARDA), and the DOD, including the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense and the Defense Advanced Research Projects Agency. One of us (M.S.) serves as OWS chief advisor. government was based on experience with Zika and the Zika Leadership Group led by the National Institutes of Health (NIH) and the assistant secretary for preparedness and response (ASPR). The concept of an integrated structure for Covid-19 countermeasure research and development across the U.S. The initiative was premised on setting a “stretch goal” - one that initially seemed impossible but that is becoming increasingly achievable. government typically supports product development and vaccine distribution. The partnership grew out of an acknowledged need to fundamentally restructure the way the U.S. OWS is providing support to promising candidates and enabling the expeditious, parallel execution of the necessary steps toward approval or authorization of safe products by the Food and Drug Administration (FDA). (12:02) DownloadĪnnounced on May 15, Operation Warp Speed (OWS) - a partnership of the Department of Health and Human Services (HHS), the Department of Defense (DOD), and the private sector - aims to accelerate control of the Covid-19 pandemic by advancing development, manufacturing, and distribution of vaccines, therapeutics, and diagnostics. Jason Schwartz on processes for determining the safety and efficacy of Covid-19 vaccine candidates and for distributing vaccines. The most trusted, influential source of new medical knowledge and clinical best practices in the world.

#OPERATION WARP SPEED VACCINES LICENSE#

Information and tools for librarians about site license offerings. Valuable tools for building a rewarding career in health care. The authorized source of trusted medical research and education for the Chinese-language medical community. The most advanced way to teach, practice, and assess clinical reasoning skills. Information, resources, and support needed to approach rotations - and life as a resident. The most effective and engaging way for clinicians to learn, improve their practice, and prepare for board exams. NEW! Peer-reviewed journal featuring in-depth articles to accelerate the transformation of health care delivery.Ĭoncise summaries and expert physician commentary that busy clinicians need to enhance patient care.

#OPERATION WARP SPEED VACCINES TRIAL#

NEW! A digital journal for innovative original research and fresh, bold ideas in clinical trial design and clinical decision-making.

Operation warp speed vaccines